Synoflex Patch
NDC Package 70512-015-15
Package Information
Synoflex Patch patches is adults and children over 12 years: Clean and dry the affected area Open pouch and remove one patchRemove the protective film from the patch and apply patch to the affected areaReseal pouch containing unused patches after each useUse 1 patch for up to 12 hoursChildren 12 years or younger: ask a doctor. This formulation utilizes a patch delivery system. Marketed by Sola Pharmaceuticals, this product is identified by NDC 70512-015 and is authorized under FDA application M017.
Identification & Billing
- RxCUI: 2600301 - lidocaine HCl 4 % / menthol 5 % Medicated Patch
- RxCUI: 2600301 - lidocaine hydrochloride 0.04 MG/MG / menthol 0.05 MG/MG Medicated Patch
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 70512 - Sola Pharmaceuticals
- 70512-015 - Synoflex Patch
- 70512-015-15 - 3 POUCH in 1 BOX / 5 g in 1 POUCH
- 70512-015 - Synoflex Patch
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 70512-015-15 identifies a specific commercial package of 3 pouch in 1 box / 5 g in 1 pouch of Synoflex Patch, a human over the counter drug labeled by Sola Pharmaceuticals. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This patch is formulated for topical use and contains lidocaine hydrochloride; menthol as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Sola Pharmaceuticals on April 28, 2022. The current certification is valid through December 31, 2026.
How is this Sola Pharmaceuticals product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 70512001515. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.